Trials / Recruiting
RecruitingNCT06794970
Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.
Detailed description
At the kidney transplant follow-up clinic of the UO Nephrology, Dialysis and Transplantation Unit of the IRCCS AOUBO Policlinico di Sant'Orsola, directed by Prof. G. La Manna, all patients with a diagnosis of cAMR made since 01/01/2018 and patients with a new diagnosis of cAMR made after the approval of this protocol by the Ethics Committee will be enrolled. The study will last 5 years and 6 months.
Conditions
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2028-11-01
- Completion
- 2028-11-01
- First posted
- 2025-01-27
- Last updated
- 2025-01-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06794970. Inclusion in this directory is not an endorsement.